Trending Now
Amarin Corporation Plc (NASDAQ:AMRN) Will Commercialize VAZKEPA In Q3 2021: Reports...
Amarin Corporation Plc (NASDAQ:AMRN) posted revenues of $142.2 million in revenues in Q1 2021. Its US operations accounted for a significant chunk of revenues...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Argentina Makes An Official Announcement Of The COVID-19 Vaccine Supply Deal...
Moderna Inc (NASDAQ: MRNA) is back in the news. This time it regards a vaccine procurement deal. Recently, Argentina makes an official announcement of...
MAKE IT MODERN
LATEST REVIEWS
US FDA Places Mind Medicine Inc.’s (NASDAQ: MNMD) IND Supporting Phase...
Mind Medicine Inc. (NASDAQ: MNMD) has announced that the US FDA has placed a clinical hold on its IND application that intends to support...
MAKE IT MODERN
PERFORMANCE TRAINING
Aptose Biosciences Inc.’s (NASDAQ: APTO) HM43239 Shows Durable Activity In Refractory/Relapsed Acute Myeloid Leukemia
Aptose Biosciences Inc. (NASDAQ: APTO) has announced that oral myeloid kinome inhibitor HM43239 has shown durable single-agent activity in refractory/relapsed acute myeloid leukemia patients....
MEIP Stock sees a Significant Surge Amidst Strategic Evaluation
Shares of MEI Pharma, Inc. (NASDAQ: MEIP) experienced a remarkable 21.33% increase today, closing at $3.47. The momentum continued after hours, with...
Novavax Inc. (NASDAQ: NVAX) Dips 4.2% Following Delay Reports That Its COVID-19 Vaccine Launch...
Novavax Inc. (NASDAQ: NVAX) dropped 4.2% following a report in the Economic Times that the launch of its COVID-19 vaccine in India could take...
PDL BioPharma Inc (NASDAQ:PDLI) Signs a Definitive Agreement with SWK Holdings Corporation for the...
PDL BioPharma Inc (NASDAQ:PDLI) was founded as Protein Design Labs, Inc. in 1986. Its founders were motivated by the need to impact patients living...
Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) Incorporates Guidance from the FDA into the Global Phase 1b/2b...
A majority of patients with COVID-19 respiratory tract infections suffer from impaired oxygen levels. However, according to Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) and its affiliated...
MAKE IT MODERN
